Glycemic Control in Adult Surgical Patients Receiving Regular Insulin Added to Parenteral Nutrition vs Insulin Glargine: A Retrospective Chart Review.

Stephanie TruongAnnie ParkSalem KamalayNancy HungJesse G MeyerNicole NguyenAmanda Momenzadeh

Published in: Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition (2019)

RI-in-PN is recommended over insulin glargine because of the higher likelihood of achieving glycemic control and, in patients with DM, lower risk of hypoglycemic events. Large, randomized controlled trials are needed to further guide prescribing practice.

Keyphrases

glycemic control
type diabetes
blood glucose
primary care
weight loss
randomized controlled trial
insulin resistance
healthcare
clinical trial
skeletal muscle
metabolic syndrome
systematic review